Hispanic blood cancer patients living at the U.S./Mexico border may have lower overall survival than those who live in other parts of Texas.

Researchers designed a calculator to predict who among those receiving treatment for two forms of acute leukemia are at highest risk.

Investigators wanted to see if blinatumomab could increase survival rates free from leukemia and be less toxic than intensive chemotherapy.

Recent legislation may help narrow the gap between FDA approval of cancer medications for adults and children.

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

“I was able to give someone a second chance on life in exchange for being sore for a couple of days. That made it easy for me to say yes,”